VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
-2.21%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$78.1B
AUM Growth
-$1.98B
(-2.5%)
Cap. Flow
-$6.87B
Cap. Flow
% of AUM
-8.79%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
1,440
New
63
Increased
853
Reduced
452
Closed
54
Top Buys
| 1 |
Kinross Gold
KGC
|
$414M |
| 2 |
C.H. Robinson
CHRW
|
$310M |
| 3 |
Tyler Technologies
TYL
|
$302M |
| 4 |
Merck
MRK
|
$276M |
| 5 |
Advanced Micro Devices
AMD
|
$270M |
Top Sells
| 1 |
Lam Research
LRCX
|
$11.3B |
| 2 |
NVIDIA
NVDA
|
$398M |
| 3 |
Salesforce
CRM
|
$270M |
| 4 |
Autodesk
ADSK
|
$262M |
| 5 |
Clorox
CLX
|
$237M |
Sector Composition
| 1 | Technology | 40.77% |
| 2 | Materials | 22.23% |
| 3 | Healthcare | 8.64% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Dentsply Sirona
XRAY
$2.86B
| $27K | ﹤0.01% |
1,446
-110
| -7% | -$2.05K |
|
1327
Intellia Therapeutics
NTLA
$1.25B
| $26K | ﹤0.01% |
2,188
+594
| +37% | +$7.06K |
|
1328
Beam Therapeutics
BEAM
$1.88B
| $25K | ﹤0.01% |
988
+138
| +16% | +$3.49K |
|
1329
Azenta
AZTA
$1.35B
| $24K | ﹤0.01% |
473
-163
| -26% | -$8.27K |
|
1330
iShares Russell 1000 Value ETF
IWD
$63.7B
| $24K | ﹤0.01% |
132
+63
| +91% | +$11.5K |
|
1331
VanEck CLO ETF
CLOI
$1.15B
| $23K | ﹤0.01% |
437
+199
| +84% | +$10.5K |
|
1332
Evolent Health
EVH
$1.1B
| $23K | ﹤0.01% |
2,033
+677
| +50% | +$7.66K |
|
1333
VanEck IG Floating Rate ETF
FLTR
$2.56B
| $23K | ﹤0.01% |
898
+409
| +84% | +$10.5K |
|
1334
NeoGenomics
NEO
$1.04B
| $22K | ﹤0.01% |
1,360
-364
| -21% | -$5.89K |
|
1335
VanEck Morningstar Wide Moat ETF
MOAT
$12.7B
| $22K | ﹤0.01% |
241
+114
| +90% | +$10.4K |
|
|
NLOP
1336
Net Lease Office Properties
NLOP
$436M
| $22K | ﹤0.01% |
717
+301
| +72% | +$9.24K |
|
1337
Grid Dynamics Holdings
GDYN
$666M
| $21K | ﹤0.01% |
942
+70
| +8% | +$1.56K |
|
|
HPP
1338
Hudson Pacific Properties
HPP
$1.08B
| $21K | ﹤0.01% |
6,870
-19,848
| -74% | -$60.7K |
|
1339
VanEck Long Muni ETF
MLN
$533M
| $21K | ﹤0.01% |
1,163
-1
| -0.1% | -$18 |
|
1340
VanEck Emerging Markets High Yield Bond ETF
HYEM
$415M
| $20K | ﹤0.01% |
1,046
+394
| +60% | +$7.53K |
|
1341
VeriSign
VRSN
$25.9B
| $20K | ﹤0.01% |
98
-23,052
| -100% | -$4.7M |
|
1342
10x Genomics
TXG
$1.69B
| $18K | ﹤0.01% |
1,270
-114
| -8% | -$1.62K |
|
1343
Technology Select Sector SPDR Fund
XLK
$84B
| $18K | ﹤0.01% |
78
+34
| +77% | +$7.85K |
|
|
XIFR
1344
XPLR Infrastructure, LP
XIFR
$966M
| $17K | ﹤0.01% |
946
+38
| +4% | +$683 |
|
1345
VanEck CEF Muni Income ETF
XMPT
$169M
| $17K | ﹤0.01% |
771
-2
| -0.3% | -$44 |
|
1346
iShares Russell Top 200 Growth ETF
IWY
$15B
| $16K | ﹤0.01% |
+68
| New | +$16K |
|
1347
Vanguard Mega Cap Growth ETF
MGK
$29.2B
| $16K | ﹤0.01% |
+46
| New | +$16K |
|
1348
Maravai LifeSciences
MRVI
$341M
| $16K | ﹤0.01% |
2,853
+1,266
| +80% | +$7.1K |
|
1349
Sasol
SSL
$4.4B
| $15K | ﹤0.01% |
3,395
-30,407
| -90% | -$134K |
|
1350
Vanguard Mid-Cap ETF
VO
$87.4B
| $15K | ﹤0.01% |
58
+27
| +87% | +$6.98K |
|